Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study

被引:1
|
作者
Rosenkranz, Simone H. [1 ]
Wichmand, Charlotte H. [1 ]
Smedegaard, Laerke [1 ]
Moller, Sidsel [1 ,2 ]
Bjerre, Jenny [1 ]
Schou, Morten [1 ]
Torp-Pedersen, Christian [3 ,4 ]
Philbert, Berit T. [5 ]
Larroude, Charlotte [1 ]
Melchior, Thomas M. [6 ]
Nielsen, Jens C. [7 ,8 ]
Johansen, Jens B. [9 ]
Riahi, Sam [10 ,11 ]
Holmberg, Teresa [12 ]
Gislason, Gunnar [1 ,13 ,14 ]
Ruwald, Anne-Christine [5 ,6 ]
机构
[1] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Hellerup, Denmark
[2] Emergency Med Serv Copenhagen, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
[4] Nordsjaellands Hosp, Dept Cardiol, Hillerod, Denmark
[5] Copenhagen Univ Hosp, Rigshospitalet, Dept Cardiol, Copenhagen, Denmark
[6] Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark
[7] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[8] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[9] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[10] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[11] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
[12] Danish Canc Soc, Res Ctr, Copenhagen, Denmark
[13] Danish Heart Fdn, Copenhagen, Denmark
[14] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
关键词
Implantable Cardioverter Defibrillator; Workforce affiliation; Return-to-work; Employment maintenance; Epidemiology; Risk markers; HEART-FAILURE; SICK-LEAVE; FOLLOW-UP; ICD; HEALTH; DEPRESSION; IMPACT; RISK; UNEMPLOYMENT; EMPLOYMENT;
D O I
10.1093/ehjqcco/qcad054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim There are a paucity of studies investigating workforce affiliation in connection with first-time implantable cardioverter defibrillator (ICD)-implantation. This study explored workforce affiliation and risk markers associated with not returning to work in patients with ICDs.Methods Using the nationwide Danish registers, patients with a first-time ICD-implantation between 2007 and 2017 and of working age (30-65 years) were identified. Descriptive statistic and logistic regression models were used to describe workforce affiliation and to estimate risk markers associated with not returning to work, respectively. All analyses were stratified by indication for implantation (primary and secondary prevention).Results Of the 4659 ICD-patients of working age, 3300 patients (71%) were members of the workforce (employed, on sick leave or unemployed) (primary: 1428 (43%); secondary:1872 (57%)). At baseline, 842 primary and 1477 secondary prevention ICD-patients were employed. Of those employed at baseline, 81% primary and 75% secondary prevention ICD-patients returned to work within 1 year, whereof more than 80% remained employed the following year. Among patients receiving sick leave benefits at baseline, 25% were employed after 1 year. Risk markers of not returning to work were 'younger age' in primary prevention ICD-patients, while 'female sex', left ventricular ejection fraction 'LVEF & LE;40', 'lower income', and '& GE;3 comorbidities' were risk markers in secondary prevention ICD-patients. Lower educational level was a risk marker in both patient groups.Conclusion High return-to-work proportions following ICD-implantation, with a subsequent high level of employment maintenance were found. Several significant risk markers of not returning to work were identified including 'lower educational level' that posed a risk in both patient groups.Trial registration number Capital Region of Denmark, P-2019-051. Graphical Abstract Workforce affiliation in primary and secondary prevention ICD-patients.
引用
收藏
页码:314 / 325
页数:12
相关论文
共 50 条
  • [41] Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy
    Cavalcanti, Rafael
    Aboul-Hosn, Nael
    Morales, Gustavo
    Abdel-Latif, Ahmed
    ANGIOLOGY, 2018, 69 (04) : 297 - 302
  • [42] Impact of early complications on outcomes among patients with implantable cardioverter defibrillator in primary prevention
    Piot, O.
    Ascoeta, S.
    Bouzeman, A.
    Defaye, P.
    Perrier, M. C.
    Leclercq, C.
    Sadoul, N.
    Gras, D.
    Marijon, E.
    Boveda, S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 690 - 690
  • [43] Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention
    Ascoeta, Maria Soledad
    Marijon, Eloi
    Defaye, Pascal
    Klug, Didier
    Beganton, Frankie
    Perier, Marie-Cecile
    Gras, Daniel
    Algalarrondo, Vincent
    Deharo, Jean-Claude
    Leclercq, Christophe
    Fauchier, Laurent
    Babuty, Dominique
    Bordachar, Pierre
    Sadoul, Nicolas
    Boveda, Serge
    Piot, Olivier
    HEART RHYTHM, 2016, 13 (05) : 1045 - 1051
  • [44] Appropriate and inappropriate implantable cardioverter defibrillator interventions during secondary prevention
    Van der Velden, Lieven B. J.
    Huybrechts, Wim
    Adriaensens, Bert
    Ector, Joris
    Ector, Hugo
    Willems, Rik
    Heidbuechel, Hein
    ACTA CARDIOLOGICA, 2008, 63 (01) : 39 - 45
  • [45] Impact of Implantable Cardioverter-Defibrillator Therapy on a Secondary Prevention Population
    Rathod, Ankit
    Badheka, Apurva
    Deshmukh, Abhishek
    JAMA INTERNAL MEDICINE, 2013, 173 (22) : 2093 - 2094
  • [46] Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States
    Maraey, Ahmed
    Yazdi, Vahid
    Chaaban, Nourhan
    Aglan, Amro
    Elzanaty, Ahmed
    Moustafa, Abdelmoniem
    Karim, Saima
    He, Beixin Julie
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024, 47 (09): : 1241 - 1251
  • [47] IMPACT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FOR PRIMARY PREVENTION IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
    Cabrera-Bueno, F.
    Molina-Mora, M. J.
    Pena-Hernandez, J.
    Leruite, I.
    Alzueta, J.
    Barrera-Cordero, A.
    De Teresa, E.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 : S92 - S93
  • [48] Electrical storms in patients with an implantable cardioverter defibrillator: Primary vs. secondary prophylaxis
    Tint, Diana
    Micu, Sorin
    Petris, Antoniu
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2016, 628 (01) : 1 - 6
  • [49] Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study
    Ruwald, A. C.
    Gislason, G. H.
    Vinther, M.
    Johansen, J. B.
    Nielsen, J. C.
    Philbert, B. T.
    Torp-Pedersen, C.
    Riahi, S.
    Jons, C.
    EUROPACE, 2018, 20 : F217 - F224
  • [50] Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients
    Wilkoff, BL
    Hess, M
    Young, J
    Abraham, WT
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (09) : 1002 - 1009